Researchers
-
Alba Oliveras
Cardiovascular clinical research
-
Anna Contra Carne
Cardiovascular clinical research
-
Antonio Carol Ruiz
Cardiovascular clinical research
-
Antonia Ortega Díaz
Cardiovascular clinical research
-
Carlos Enrique Sabbagh Fajardo
Cardiovascular clinical research
-
carmen martin
Cardiovascular clinical research
-
Elizabeth Mena Sebastià
Cardiovascular clinical research
-
Joan Pol Monteys Montblanch
Cardiovascular clinical research
-
José Navarrete Monte
Cardiovascular clinical research
-
Maria Del Señor Cortés Fernández
Cardiovascular clinical research
-
Marta Camprecios Crespo
Cardiovascular clinical research
-
Mercè Faraudo
Cardiovascular clinical research
-
Miriam Garcia Bermudez
Cardiovascular clinical research
-
Olga Guri
Cardiovascular clinical research
-
Peter Castellanos
Cardiovascular clinical research
-
Pilar Sánchez Chamero
Cardiovascular clinical research
Phd -
Raúl Lafuente Masqueda
Cardiovascular clinical research
-
Román Freixa Pamías
Cardiovascular clinical research
Phd -
Sandra Lara Sanmartin
Cardiovascular clinical research
Contact the group
Form-
Freixa R, Blanch P, Rodríguez Latre ML, Basile L, Sánchez Chamero P, Martínez-Rubio A, Lupón J. 123/19
Impact of an integral assistance model between primary care and cardiology on the management of patients with ischemic heart disease or atrial fibrillation.
J Comp Eff Res. 2019;8(2):103-111.
-
Sanchis J, Ariza-Solé A, Abu-Assi E, Alegre O, Alfonso F, Barrabés JA, Baz JA, Carol A, Díez Villanueva P, García Del Blanco B, Elízaga J, Fernandez E, García Del Egido A, García Picard J, Gómez Blázquez I, Gómez Hospital JA, Hernández-Antolín R, Llibre C, Marín F, Martí Sánchez D, Martín R, Martínez Sellés M, Miñana G, Morales Gallardo MJ, Núñez J, Pérez de Prado A, Pinar E, Sanmartin M, Sionis A, Villa A, Marrugat J, Bueno H. 181/19
Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design.
Rev Esp Cardiol (Engl Ed). 2019;72(2):154-159.
-
Barrabés JA, Bardají A, Jiménez-Candil J, Bodí V, Freixa R, Vázquez R, Sánchez-Ramos JG, May A, Rollán MJ, Fernández-Ortiz A. 7/18
Characteristics and Outcomes of Patients Hospitalized With Suspected Acute Coronary Syndrome in Whom the Diagnosis is not Confirmed.
Am J Cardiol. 2018;122(10):1604-1609.
-
Freixa R, Gràcia PB, Rodríguez Latre ML, Basile L, Chamero PS, Martínez-Rubio A, Lupón J, Trabajo de Atención Integrada Cardiología-Primaria Atención In the Hospital Area Moisès Broggi G. 20/18
Impact of an integral assistance model between primary care and cardiology on the management of patients with ischemic heart disease or atrial fibrillation.
J Comp Eff Res. 2018 Dec 14
-
Ariza-Solé A, Díez-Villanueva P, Carol A, Bonanad C, Alegre O, Aboal J. 1431
Selection of the Best of 2016 on the Management of Acute Coronary Syndromes in Elderly Patients.
Rev Esp Cardiol (Engl Ed). 2017;70(1):61-62.
-
Bernal E, Ariza-Solé A, Formiga F, Abu-Assi E, Carol A, Galián L, Bayés-Genís A, Saldivar HG, Díez-Villanueva P, Sellés MM; Influence of the Diagnosis of Severe Aortic Stenosis (IDEAS) Registry Investigators. 1433
Conservative management in very elderly patients with severe aortic stenosis: Time to change?
J Cardiol. 2017;69(6):883-887.
-
Blanch P, Freixa-Pamias R. 1395
Optimum search strategy for asymptomatic target organ damage in hypertension.
Vasc Hypertensive Risk 2017;34(4):145-148.
-
Rossello X, Muñoz-Guijosa C, Mena E, Camprecios M, Mendez AB, Borras X, Padro JM. 1426
Tricuspid valve replacement with mechanical prostheses: Short and long-term outcomes.
J Card Surg. 2017 Sep;32(9):542-549.
-
Armario P, Jericó C, Vila L, Freixa R, Martin-Castillejos C, Rotllan M, and among the members of the Vascular Risk Integrated Care Area. 1413
Integrated Management Area of Vascular Risk: A new organizational model for global control of risk factors.
Vasc Hypertension and Risk 2017;34:72-77.
-
Oliveras A, Dalfó-Pibernat A, Jdid N, Mayor E, Pérez-Romero L, Gibert E, Dalfó-Baqué A. 1305
Determination of arm circumference for correct measurement of blood pressure. Results of an intervention study.
Vasc Hypertensive Risk 2015;32(1):6-11.
Projects
-
- Year 2020
- HSDMB
Observational study to evaluate the Net Clinical Benefit of Edoxaban in patients with non-valvular atrial fibrillation, according to usual clinical practice in Spain. BENEFIT Registry.
-
DISTRICT ATTORNEY:
Daiichi Sankyo Spain, SAU
-
TYPE E:
EPA-OD
-
- Year 2020
- HSDMB
Behavior of edoxaban in patients with non-valvular atrial fibrillation and heart failure in Spain - Behavior of edoxaban in LVEF and HF. I study EMAYIC.
-
DISTRICT ATTORNEY:
Spanish Society of Cardiology (SEC)
-
TYPE E:
EPA-SP
-
Cardiovascular clinical research
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Effect on the functional capacity of treatment with intravenous iron or oral iron, compared with placebo, in patients with heart failure with preserved left ventricular ejection fraction and iron deficiency anemia.
-
DISTRICT ATTORNEY:
Dr. José Luis Morales Rull - Lleida Biomedical Research Institute (IRB)
-
TYPE E:
RD2015
-
Cardiovascular clinical research
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Drug use study (EUF) of alirocumab in Europe to evaluate the effectiveness of the recommended administration in order to avoid very low levels of C-LDL.
-
DISTRICT ATTORNEY:
Sanofi-Aventis Recherche & Développement (“SAR&D”)
-
TYPE E:
EPA-LA
-
Cardiovascular clinical research
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Heart failure Events reduction with Remote Monitoring and eHealth Support Investigator Initiated Trial.
-
DISTRICT ATTORNEY:
Dr. Josep Comín Colet. HUB
-
TYPE E:
PIN-NO-EPA
-
Cardiovascular clinical research
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Record of myocardial infarction without ST segment elevation.
-
DISTRICT ATTORNEY:
European Society of Cardiology
-
TYPE E:
PI
-
Cardiovascular clinical research
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Non-interventional and transversal study to describe the management of NACO treatment in elderly patients with non-valvular atrial fibrillation (NAFV) in Spain. (RE-BELD studio).
-
DISTRICT ATTORNEY:
Boehringer Ingelheim Spain
-
TYPE E:
EPA-SP
-
Cardiovascular clinical research
Researcher
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Treatment with beta-blockers after myocardial infarction without reduced ejection fraction.
-
DISTRICT ATTORNEY:
Carlos III National Cardiovascular Research Center (CNIC), Spain
-
TYPE E:
RD2015
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Effect on the functional capacity of treatment with intravenous iron or oral iron, compared with placebo, in patients with heart failure with preserved left ventricular ejection fraction and iron deficiency anemia.
-
DISTRICT ATTORNEY:
Dr. José Luis Morales Rull - Lleida Biomedical Research Institute (IRB)
-
TYPE E:
RD2015
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
Drug use study (EUF) of alirocumab in Europe to evaluate the effectiveness of the recommended administration in order to avoid very low levels of C-LDL.
-
DISTRICT ATTORNEY:
Sanofi-Aventis Recherche & Développement (“SAR&D”)
-
TYPE E:
EPA-LA
- Self control in carriers Mechanical prosthesis
- Cryptogenetic stroke
- Spontaneous coronary dissection
- Atrial fibrillation, anticoagulation and stroke / bleeding
- Integrated cardiology primary care
- LDL control in post-SCA patients
- Impact of IC Functional Unit on Hospital Admissions / Re-admissions
